Home > News > Molecular Imprints, Inc. Secures Carl Zeiss as Investor
December 2nd, 2003
Molecular Imprints, Inc. Secures Carl Zeiss as Investor
Abstract:
Molecular Imprints, Inc. (MII) has reached an investment and collaboration agreement with Carl Zeiss SMT AG, a global supplier to the semiconductor industry and a wholly owned corporation of the German-based Carl Zeiss Group. Carl Zeiss SMT has agreed to make an equity investment in MII and has also obtained the exclusive
rights to distribute MII's imprint lithography equipment in Europe for its LEO Division. The Carl Zeiss SMT investment is part of MII's Series B $30 million funding round.
Source:
PRNewswire
Bookmark:
| Related News Press |
Investments/IPO's/Splits
Daikin Industries becomes OCSiAl shareholder July 27th, 2021
INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||